Zuranolone to face challenges in Japan’s MDD market despite demonstrating rapid onset of action:… EP News Bureau Oct 22, 2024 Shionogi's zuranolone faces hurdles in Japan's MDD market, balancing rapid efficacy against safety concerns and established…
When and which COVID-19 vaccines are likely to be available in Asia Reuters Nov 26, 2020 If regulators approve any of the vaccines in coming weeks, the companies have said distribution could begin almost immediately…
